drugset / Trial / NCT01543269

A Clinical Study to Evaluate the Safety,Tolerability and PK of ZYT1, Following Oral Administration in Healthy Volunteers

NCT01543269 ↗

Phase 1 Terminated 24 enrolled Zydus Lifesciences Limited
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This is a clinical study to evaluate the safety, tolerability and pharmacokinetics of ZYT1, following oral administrations in healthy volunteers. The study shall be divided into four plans as given below: 1. Plan I: Single dose escalation trial 2. Plan II: Multiple dose escalation trial 3. Plan III: Food effect trial. 4. Plan IV: Gender Effect trial. The safety and tolerability shall be evaluated using physical examinations, Standard laboratory tests (hematology, biochemistry and urine examination), electrocardiogram (ECG) and thyroid scanning. Spontaneously reported and solicited adverse events will also be used for safety parameters.

Timeline

Start
2010-02
Primary completion
2012-07
Completion
2012-07

Outcome

Outcome not reported

Stopped: “Safety concerns”

Drugs

EvaluationDrugModalityDoseRoute
Comparator ZYT1 Unknown 0.5 mg Oral
Comparator ZYT1 Unknown 1 mg Oral
Comparator ZYT1 Unknown 2 mg Oral
Comparator ZYT1 Unknown 4 mg Oral
Comparator ZYT1 Unknown 8 mg Oral
Comparator ZYT1 Unknown 16 mg Oral
Comparator ZYT1 Unknown 32 mg Oral
Comparator ZYT1 Unknown 64 mg Oral